Analysis of the Plasma Proteome in COPD: Novel Low Abundance Proteins Reflect the Severity of Lung Remodeling

References

• Nussbaumer-Ochsner Y, Rabe KF. Systemic manifestations of COPD. Chest 2011; 139:165–173.
   PubMed Web of Science ®Google Scholar
• Patel AR, Hurst JR. Extrapulmonary comorbidities in chronic obstructive pulmonary disease: state of the art. Expert Rev Respir Med 2011; 5: 647–662.
   PubMed Web of Science ®Google Scholar
• Yoshida T, Tuder RM. Pathobiology of cigarette smoke-induced chronic obstructive pulmonary disease. Physiol Rev 2007; 87:1047–1082.
   PubMed Web of Science ®Google Scholar
• Punturieri A, Croxton TL, Weinmann GG, Kiley JP. Chronic obstructive pulmonary disease: a view from the NHLBI. Am J Respir Crit Care Med 2008; 178:441–443.
   PubMed Web of Science ®Google Scholar
• Rabe KF, Hurd S, Anzueto A, Barnes PJ, Buist SA, Calverley P, Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176:532–555.
   PubMed Web of Science ®Google Scholar
• Godtfredsen NS, Lam TH, Hansel TT, Leon ME, Gray N, Dresler C, COPD-related morbidity and mortality after smoking cessation: status of the evidence. Eur Respir J 2008; 32:844–853.
   PubMed Web of Science ®Google Scholar
• Minino AM, Murphy SL. Death in the United States, 2010; NCHS Data Brief Jul(99):1–8.
   Google Scholar
• Ubhi BK, Riley JH, Shaw PA, Lomas DA, Tal-Singer R, MacNee W, Metabolic profiling detects biomarkers of protein degradation in COPD patients. Eur Respir J 2012; 40:345–355.
   PubMed Web of Science ®Google Scholar
• Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, Edwards L, Evaluation of COPD longitudinally to identify predictive surrogate end-points (ECLIPSE). Eur Respir J 2008; 31:869–873.
   PubMed Web of Science ®Google Scholar
• Sin DD, Miller BE, Duvoix A, Man SF, Zhang X, Silverman EK, Serum PARC/CCL-18 concentrations and health outcomes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 183:1187–1192.
   PubMed Web of Science ®Google Scholar
• Sin DD, Vestbo J. Biomarkers in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2009; 6:543–545.
   PubMedGoogle Scholar
• Tzortzaki EG, Lambiri I, Vlachaki E, Siafakas NM. Biomarkers in COPD. Curr Med Chem 2007; 14:1037–1048.
   PubMed Web of Science ®Google Scholar
• Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H, Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 2007; 62:595–601.
   PubMed Web of Science ®Google Scholar
• Pinto-Plata VM, Mullerova H, Toso JF, Feudjo-Tepie M, Soriano JB, Vessey RS, C-reactive protein in patients with COPD, control smokers and non-smokers. Thorax 2006; 61:23–28.
   PubMed Web of Science ®Google Scholar
• Devanarayan V, Scholand MB, Hoidal J, Leppert MF, Crackower MA, O'Neill GP, Identification of distinct plasma biomarker signatures in patients with rapid and slow declining forms of COPD. COPD 2010; 7:51–58.
   PubMedGoogle Scholar
• Ilumets H, Mazur W, Toljamo T, Louhelainen N, Nieminen P, Kobayashi H, Ageing and smoking contribute to plasma surfactant proteins and protease imbalance with correlations to airway obstruction. BMC Pulm Med 2011; 11:19.
   PubMedGoogle Scholar
• Agusti A, Edwards LD, Rennard SI, MacNee W, Tal-Singer R, Miller BE, Persistent systemic inflammation is associated with poor clinical outcomes in COPD: a novel phenotype. PLoS One 2012; 7(5):e37483.
   PubMed Web of Science ®Google Scholar
• Celli BR, Locantore N, Yates J, Tal-Singer R, Miller BE, Bakke P, Inflammatory biomarkers improve clinical prediction of mortality in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 185:1065–1072.
   PubMed Web of Science ®Google Scholar
• Duvoix A, Dickens J, Haq I, Mannino D, Miller B, Tal-Singer R, Blood fibrinogen as a biomarker of chronic obstructive pulmonary disease. Thorax 2013; 68:670–676.
   PubMed Web of Science ®Google Scholar
• Thomsen M, Dahl M, Lange P, Vestbo J, Nordestgaard BG. Inflammatory biomarkers and comorbidities in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2012; 186:982–988.
   PubMed Web of Science ®Google Scholar
• Verrills NM, Irwin JA, He XY, Wood LG, Powell H, Simpson JL, Identification of novel diagnostic biomarkers for asthma and chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2011; 183:1633–1643.
   PubMed Web of Science ®Google Scholar
• Auffray C, Adcock IM, Chung KF, Djukanovic R, Pison C, Sterk PJ. An integrative systems biology approach to understanding pulmonary diseases. Chest 2010; 137:1410–1416.
   PubMed Web of Science ®Google Scholar
• Chen H, Wang D, Bai C, Wang X. Proteomics-based biomarkers in chronic obstructive pulmonary disease. J Proteome Res 2010; 9:2798–2808.
   PubMed Web of Science ®Google Scholar
• Patel BB, Barrero CA, Braverman A, Kim PD, Jones KA, Chen DE, Assessment of two immunodepletion methods: off-target effects and variations in immunodepletion efficiency may confound plasma proteomics. J Proteome Res 2012; 11:5947–5958.
   PubMed Web of Science ®Google Scholar
• Qian WJ, Kaleta DT, Petritis BO, Jiang H, Liu T, Zhang X, Enhanced detection of low abundance human plasma proteins using a tandem IgY12-SuperMix immunoaffinity separation strategy. Mol Cell Proteomics 2008; 7:1963–1973.
   PubMed Web of Science ®Google Scholar
• Faca V, Pitteri SJ, Newcomb L, Glukhova V, Phanstiel D, Krasnoselsky A, Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res 2007; 6:3558–3565.
   PubMed Web of Science ®Google Scholar
• Zhang Q, Faca V, Hanash S. Mining the plasma proteome for disease applicat-ions across seven logs of protein abundance. J Proteome Res 2011; 10:46–50.
   PubMed Web of Science ®Google Scholar
• Qian WJ, Jacobs JM, Liu T, Camp DG, 2nd, Smith RD. Advances and challenges in liquid chromatography-mass spectrometry-based proteomics profiling for clinical applications. Mol Cell Proteomics 2006; 5:1727–1744.
   PubMed Web of Science ®Google Scholar
• Bandow JE, Baker JD, Berth M, Painter C, Sepulveda OJ, Clark KA, Improved image analysis workflow for 2-D gels enables large-scale 2-D gel-based proteomics studies–COPD biomarker discovery study. Proteomics 2008; 8:3030–3041.
   PubMed Web of Science ®Google Scholar
• Rana GS, York TP, Edmiston JS, Zedler BK, Pounds JG, Adkins JN, Proteomic biomarkers in plasma that differentiate rapid and slow decline in lung function in adult cigarette smokers with chronic obstructive pulmonary disease (COPD). Anal Bioanal Chem 2010; 397:1809–1819.
   PubMed Web of Science ®Google Scholar
• York TP, van den Oord EJ, Langston TB, Edmiston JS, McKinney W, Webb BT, High-resolution mass spectrometry proteomics for the identification of candidate plasma protein biomarkers for chronic obstructive pulmonary disease. Biomarkers 2010; 15:367–377.
   PubMed Web of Science ®Google Scholar
• Fang Y, Robinson DP, Foster LJ. Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics. J Proteome Res 2010; 9:1902–1912.
   PubMed Web of Science ®Google Scholar
• Ke E, Patel BB, Liu T, Li XM, Haluszka O, Hoffman JP, Proteomic analyses of pancreatic cyst fluids. Pancreas 2009; 38:e33–42.
   PubMed Web of Science ®Google Scholar
• Xie LQ, Zhao C, Cai SJ, Xu Y, Huang LY, Bian JS, Novel proteomic strategy reveal combined alpha1 antitrypsin and cathepsin D as biomarkers for colorectal cancer early screening. J Proteome Res 2010; 9:4701–4709.
   PubMed Web of Science ®Google Scholar
• Bortner JD, Jr., Richie JP, Jr., Das A, Liao J, Umstead TM, Stanley A, Proteomic profiling of human plasma by iTRAQ reveals down-regulation of ITI-HC3 and VDBP by cigarette smoking. J Proteome Res 2011; 10:1151–1159.
   PubMed Web of Science ®Google Scholar
• de Torres JP, Casanova C, Pinto-Plata V, Varo N, Restituto P, Cordoba-Lanus E, Gender differences in plasma biomarker levels in a cohort of COPD patients: a pilot study. PLoS One. 6(1):e16021.
   Google Scholar
• Kim CX, Bailey KR, Klee GG, Ellington AA, Liu G, Mosley TH Jr, Sex and ethnic differences in 47 candidate proteomic markers of cardiovascular disease: the Mayo Clinic proteomic markers of arteriosclerosis study. PLoS One. 5(2):e9065.
   Google Scholar
• Han MK, Kazerooni EA, Lynch DA, Liu LX, Murray S, Curtis JL, Chronic obstructive pulmonary disease exacerbations in the COPDGene study: associated radiologic phenotypes. Radiology 2010; 261:274–282.
   Web of Science ®Google Scholar
• Han Z, Liang CG, Cheng Y, Duan X, Zhong Z, Potireddy S, Oocyte spindle proteomics analysis leading to rescue of chromosome congression defects in cloned embryos. J Proteome Res 2010; 9:6025–6032.
   PubMed Web of Science ®Google Scholar
• Sing T, Sander O, Beerenwinkel N, Lengauer T. ROCR: visualizing classifier performance in R. Bioinformatics 2005; 21:3940–3941.
   PubMed Web of Science ®Google Scholar
• Dahl M, Vestbo J, Zacho J, Lange P, Tybjaerg-Hansen A, Nordestgaard BG. C reactive protein and chronic obstructive pulmonary disease: a Mendelian randomisation approach. Thorax 2011; 66:197–204.
   PubMed Web of Science ®Google Scholar
• Hurst JR, Donaldson GC, Perera WR, Wilkinson TM, Bilello JA, Hagan GW, Use of plasma biomarkers at exacerbation of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2006; 174:867–874.
   PubMed Web of Science ®Google Scholar
• Haab BB, Geierstanger BH, Michailidis G, Vitzthum F, Forrester S, Okon R, Immunoassay and antibody microarray analysis of the HUPO Plasma Proteome Project reference specimens: systematic variation between sample types and calibration of mass spectrometry data. Proteomics 2005; 5:3278–3291.
   PubMed Web of Science ®Google Scholar
• Zethelius B, Berglund L, Sundstrom J, Ingelsson E, Basu S, Larsson A, Use of multiple biomarkers to improve the prediction of death from cardiovascular causes. N Engl J Med 2008; 358:2107–2116.
   PubMed Web of Science ®Google Scholar
• Chung KF, Adcock IM. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction. Eur Respir J 2008; 31:1334–1356.
   PubMed Web of Science ®Google Scholar
• Marciniak SJ, Ron D. Endoplasmic reticulum stress signaling in disease. Physiol Rev 2006; 86:1133–1149.
   PubMed Web of Science ®Google Scholar
• Lawson WE, Cheng DS, Degryse AL, Tanjore H, Polosukhin VV, Xu XC, Endoplasmic reticulum stress enhances fibrotic remodeling in the lungs. Proc Natl Acad Sci USA 2011; 108:10562–10567.
   PubMed Web of Science ®Google Scholar
• Kelsen SG, Duan X, Ji R, Perez O, Liu C, Merali S. Cigarette smoke induces an unfolded protein response in the human lung: a proteomic approach. Am J Respir Cell Mol Biol 2008; 38:541–550.
   PubMed Web of Science ®Google Scholar
• Malhotra D, Thimmulappa R, Vij N, Navas-Acien A, Sussan T, Merali S, Heightened endoplasmic reticulum stress in COPD lungs: The role of Nrf2-regulated proteasomal activity. Am J Respir Crit Care Med 2009; 180:1196–1207.
   PubMed Web of Science ®Google Scholar
• Van Gorp H, Delputte PL, Nauwynck HJ. Scavenger receptor CD163, a Jack-of-all-trades and potential target for cell-directed therapy. Mol Immunol 2010; 47:1650–1660.
   PubMed Web of Science ®Google Scholar
• Philippidis P, Mason JC, Evans BJ, Nadra I, Taylor KM, Haskard DO, Hemoglobin scavenger receptor CD163 mediates interleukin-10 release and heme oxygenase-1 synthesis: antiinflammatory monocyte-macrophage responses in vitro, in resolving skin blisters in vivo, and after cardiopulmonary bypass surgery. Circ Res 2004; 94:119–126.
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Alveolar macrophages as orchestrators of COPD. COPD 2004; 1:59–70.
   PubMedGoogle Scholar
• Subramaniam S, Stansberg C, Cunningham C. The interleukin 1 receptor family. Dev Comp Immunol 2004; 28:415–428.
   PubMed Web of Science ®Google Scholar
• Chen R, Li M, Zhang Y, Zhou Q, Shu HB. The E3 ubiquitin ligase MARCH8 negatively regulates IL-1beta-induced NF-kappaB activation by targeting the IL1RAP coreceptor for ubiquitination and degradation. Proc Natl Acad Sci USA 2012; 109:14128–14133.
   PubMed Web of Science ®Google Scholar
• Yang Y, Bin W, Aksoy MO, Kelsen SG. Regulation of interleukin-1beta and interleukin-1beta inhibitor release by human airway epithelial cells. Eur Respir J 2004; 24:360–366.
   PubMed Web of Science ®Google Scholar
• Barnes PJ SS, Pauwels RA. Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 2003; 22:672–688.
   PubMed Web of Science ®Google Scholar
• Wang MH, Zhou YQ, Chen YQ. Macrophage-stimulating protein and RON receptor tyrosine kinase: potential regulators of macrophage inflammatory activities. Scand J Immunol 2002; 56:545–553.
   PubMed Web of Science ®Google Scholar
• Morrison AC, Wilson CB, Ray M, Correll PH. Macrophage-stimulating protein, the ligand for the stem cell-derived tyrosine kinase/RON receptor tyrosine kinase, inhibits IL-12 production by primary peritoneal macrophages stimulated with IFN-gamma and lipopolysaccharide. J Immunol 2004; 172:1825–1832.
   PubMed Web of Science ®Google Scholar
• Ray M, Yu S, Sharda DR, Wilson CB, Liu Q, Kaushal N, Inhibition of TLR4-induced IkappaB kinase activity by the RON receptor tyrosine kinase and its ligand, macrophage-stimulating protein. J Immunol 2010; 185:7309–7316.
   PubMed Web of Science ®Google Scholar